Allergan Schedules Pershing Square-Requested Meeting For Dec.

Aug 27 2014 | 7:16am ET

Pershing Square Capital Management has a date for its showdown with Allergan Inc.

The Botox-maker set a special shareholder meeting for Dec. 18, after the hedge fund and Valeant Pharmaceuticals International delivered consent forms representing in excess of 30% of Allergan shareholders last week. Pershing Square hopes to take control of Allergan’s board at the meeting, with the new board then approving Valeant’s $53 billion offer for the company.

While it has scheduled the meeting, Allergan made clear it is not resigned to it happening: The company said its board would meet next month to evaluate the meeting request forms submitted by Pershing Square and Allergan to determine their validity. And it said it would continue to pursue an acquisition of its own in an effort to derail Valeant’s hostile takeover bid.

Pershing Square and Valeant have also sued Allergan, asking the Delaware courts to declare the consent forms valid and to order Allergan not to make any acquisitions until after the special meeting. In its filing announcing the special meeting, Allergan blasted the last request, saying that “in the face of Valeant’s hostile bid, Allergan’s board is not only entitled but obligated to consider potential alternatives.”

Allergan has sued Pershing Square and Valeant, alleging that their unusual partnership amounts to insider trading—an accusation they deny. Allergan has also called Valeant’s offer too low and criticized its business model.

Allergan also said that it had asked a federal court in California to expedite its request for an injunction barring Pershing Square from voting its 9.7% stake at the special meeting. In its lawsuit, the company has asked the court to declare the hedge fund’s purchases of its shares invalid. The same court last week rejected Allergan’s bid to expedite its lawsuit.


In Depth

'Smart Beta' Funds In Regulators' Sights, Hedgies May Be Next

Mar 26 2015 | 11:11am ET

Funds that mimic strategies used by active managers for a fraction of the cost could...

Lifestyle

Study: Both Marriage and Divorce Lead to Negative Hedge Fund Performance

Mar 25 2015 | 6:51pm ET

Trouble at home leads to trouble in the market for fund managers, according to researchers...

Guest Contributor

The Life Settlement: Yield For The Investor And Cash For The Consumer

Mar 31 2015 | 6:48am ET

Investors are languishing in a yield-starved, low-interest rate environment, looking...

 

Sponsored Content

    Mar 9 2015 | 6:35am ET

    Kelly RodriquesKelly RodriquesAs more investors look to diversify, many are beginning to use retirement funds to invest in alternative assets such as private equity and real estate. Kelly Rodriques, CEO & President of PENSCO Trust Company, explains how companies can connect with those looking to use their retirement accounts in a different way. Read more…

Editor's Note